SSX2-IP Inhibitors
SSX2-IP inhibitors are a class of chemical compounds that interact with the protein SSX2-interacting protein (SSX2-IP), modulating its biological activity. SSX2-IP is known to play a role in various cellular processes, particularly in its interactions with other protein complexes that regulate chromatin structure and gene expression. The inhibition of SSX2-IP disrupts its ability to form functional protein-protein interactions, which can lead to downstream effects on the regulation of transcriptional activity. By targeting specific sites on the SSX2-IP structure, these inhibitors can block or alter its function, leading to changes in chromatin remodeling, epigenetic modifications, and overall gene expression dynamics. This makes SSX2-IP inhibitors important tools for investigating the molecular pathways associated with chromatin-related processes.
Structurally, SSX2-IP inhibitors can vary widely, but many are designed to specifically bind to the domains of SSX2-IP responsible for protein interaction. These compounds can be small molecules or peptidomimetics, each with distinct chemical characteristics that confer specificity and selectivity for the SSX2-IP protein. Inhibition of SSX2-IP often leads to the disruption of larger protein complexes involved in chromatin modification, such as histone acetyltransferases or other chromatin-associated proteins. By studying SSX2-IP inhibitors, researchers can gain insights into the fundamental mechanisms that govern chromatin structure, transcriptional regulation, and protein complex formation in cells. The study of these inhibitors, therefore, is significant in understanding the molecular biology of gene regulation, providing insights into the broader landscape of epigenetic control.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, as a histone deacetylase inhibitor, could potentially lead to the hyperacetylation of histones, resulting in the downregulation of SSX2-IP by promoting a transcriptionally inactive state at its gene locus. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may decrease SSX2-IP expression by causing the demethylation of its gene promoter, thereby altering gene expression patterns in a way that represses the transcription of the SSX2IP gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid is known to inhibit histone deacetylase activity, which could lead to increased acetylation of histones near the SSX2-IP gene and subsequent transcriptional repression, thereby decreasing its protein expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
By inhibiting DNA methyltransferase, RG 108 could theoretically contribute to the demethylation of the SSX2-IP gene promoter, which might result in the decreased expression of the SSX2IP gene. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can inhibit aldehyde dehydrogenase, which might lead to an accumulation of acetaldehyde and subsequent alteration of DNA methylation patterns, potentially reducing the expression of SSX2-IP. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a MEK inhibitor, PD 98059 could potentially decrease the expression of SSX2-IP by inhibiting the MAPK/ERK pathway, which may be involved in the transcriptional regulation of its gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine, a DNA methyltransferase inhibitor, has the potential to reduce SSX2-IP expression by inducing DNA hypomethylation and thereby silencing the gene transcription. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
As a PARP inhibitor, Olaparib may indirectly contribute to the downregulation of SSX2-IP expression by impairing DNA repair mechanisms, which could lead to the alteration of gene expression profiles. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 disrupts the interaction between MDM2 and p53, potentially leading to the stabilization and activation of p53, which may result in the decreased expression of SSX2-IP through p53-mediated transcriptional repression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could decrease the expression of SSX2-IP by binding to retinoic acid receptors and modulating gene transcription, potentially repressing transcription factors essential for SSX2IP expression. | ||||||